Back

Blood pressure lowering effects of pharmacological and device-based interventions for resistant hypertension: a systematic review and meta-analysis

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Renal denervation in hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Kyriakoulis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Renal denervation improves metabolic parameters and reduces SCORE2-estimated cardiovascular risk in uncontrolled hypertension
Doctor V. Bytyqi (Erlangen, DE)
Abstract Slides Video
Presentation thumbnail
Long-term effects of renal denervation on hypertension management: insights from a center of excellence
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Renal denervation in contemporary clinical practice: patient profile and early outcomes
Doctor I. Nobrega Fernandes (Vila Real, PT)
Abstract Slides Video
Presentation thumbnail
Durable 13-year outcomes after renal denervation in patients with resistant arterial hypertension in Ukraine
Doctor O. Rekovets (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
Long-term effects of renal denervation on hypertension management: a systematic review and meta-analysis
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Renal denervation in hypertension

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Ambulatory blood pressure characteristics of patients with true resistant hypertension before and during titration of a standard antihypertensive regimen
29 August 2025
thumbnail
Congress Presentation
Efficacy and safety aspects of renal denervation in treatment of arterial hypertension: a systematic review and meta-analysis
27 August 2023
thumbnail
Congress Presentation
Baxdrostat for treatment of uncontrolled and resistant hypertension: a meta-analysis and systematic review
28 August 2026
thumbnail
Congress Presentation
Adherence to antihypertensive therapy and cardiovascular outcomes: an individual participant data meta-analysis of randomised controlled trials
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources